ES0157261019
ES0157261019
LABORATORIOS FARMACEUTICOS ROVI
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 743.483.000 | 763.749.000 | 2.7% |
| Cost of Revenue | 260.797.000 | 285.403.000 | 8.6% |
| Gross Profit | 482.686.000 | 478.346.000 | 0.9% |
| 296.902.000 | 298.801.000 | 0.6% | |
| Operating Income | 185.784.000 | 179.545.000 | 3.5% |
| Pretax Income | 183.263.000 | 177.690.000 | 3.1% |
| Net Income Common Stockholders | 140.442.000 | 136.881.000 | 2.6% |
| -- | -- | -- | |
| -- | -- | -- |